Users can identify over 7,500 global clinical trial sponsors, and over 500,000 management contacts (each with a business email) working at those sponsors.

BOSTON, Jan. 9, 2014 /PRNewswire-iReach/ — karmadata® today announced the launch of Sponsor Finder™, an innovative new tool for data scientists, sales and marketing professionals at Clinical Research Organizations (CROs) and other firms that sell products and services into the global clinical trials industry. Sponsor Finder™ enables linkages to the best data sources available, including management contacts from Salesforce Data.com.

Sponsor Finder™ provides detailed profiles on over 7,500 clinical trial sponsors, including Pharmaceutical, Biotech, and Medical Device companies. Each sponsor is linked to their active and historical trials enabling detailed searches and analytics by geography, size of company, disease, and number of active or planned trials. Users can follow sponsors (or drugs or diseases) of interest, and stay informed through their feed of new activity from more than 30 healthcare data sources. Finally, each sponsor has management contacts from Salesforce Data.com, making it easy to identify new names, titles, emails, phone numbers and addresses using quick filters on titles and levels.

“We created Sponsor Finder™ in response to overwhelming demand by our clients that provide products and services to support the global clinical trials industry,” said Sean Power, karmadata’s Founder and CEO. “Sales and marketing professionals at CROs are tired of being locked into complex, outdated tools with stale data. Our ® cloud provides a great responsive web user interface that allows for rapid integration of the best new data sources. We are proving that with technology, scale, and the integration of best of breed data from places like Salesforce Data.com, you can provide a much better information service at a significantly lower cost than any other provider.”


Making it easier to find and contact clinical investigators for studies based on experience in disease indications.

karmadata (www.karmadata.com) today announced the launch of its App Gallery, a revolutionary new technology platform for publishing healthcare data applications targeting user populations with very precise needs. Today also marks the official release of Indicate Investigators, the first App published in the gallery and built entirely with the karmadata API. Indicate Investigators is used by clinical operations users that need to find the best clinical investigators for any given disease indication – and then they are able to contact each investigator using emails and phone numbers supplied by the app.

“Our App Gallery represents a dramatic shift in how healthcare data applications are created, purchased, and enjoyed by the user,” said Sean Power Founder and CEO of karmadata. “We see enormous pent up demand for simple, fun to use, micro applications that are designed for a specific business purpose for specific users. We believe each App should make the user feel like it was designed for him or her personally. “

“Each clinical investigator found in the Indicate Investigators app has been linked to healthcare data across our platform, ranging from past studies, publications, grants, site and practice affiliations, payments from industry, and so much more,” said Brendan Kelleher, Chief Data Scientist of karmadata. “Our users simply type in a disease indication, and are presented with a list of investigators with experience in that indication. The list is then sorted by kdScore™ which considers all relevant data for that investigator for that indication. Each investigator has contact information such as phone number and email address.”

Indicate Investigators profiles over 300,000 clinical investigators across 4,000 disease indications, using data from sources such as the Bioresearch Monitoring Information System (BMIS – IND Filings), ClinicalTrials.gov, PubMed, Clinical Investigator Inspection List (CLIIL), National Plan and Provider Enumeration System (NPPES), and many more. The raw source data is pushed through karmadata’s technology platform, and emerges as standardized, linked data. This allows for rich profiling of each clinical investigator, and the ability to query and visualize by related entities such as disease indication, geography, drugs, sponsors, healthcare organizations and other affiliations.

About karmadata

karmadata is healthcare (big) data, simplified. The karmadata team is on a mission to change the way users obtain and interact with healthcare information. Using big data and cloud technologies, we are able to standardize and link the world’s healthcare data ranging from leading open data sources to private pharmacy and medical claims. Our users can then follow items of interest (such as diseases, drugs, physicians, or corporations) through a real time Feed, and create impactful visualizations through their Datacards.

I stumbled upon this commencement speech on WSJ.com on Friday.  It got me thinking a little bit on higher education in the US, and in particular, the core curriculum at many colleges and universities.  I think there is great value in a liberal arts education, but I always thought the core curriculum could be adjusted a little bit to guarantee some basic skills are acquired along the way.  Here is what the core curriculum looks like for the college of Arts & Sciences at my alma mater: Core Curriculum – Boston College

I like the wide spectrum of material covered and the variety of ways that it exercises the brain, but of the 15 courses needed to complete the core curriculum, I would require a computer science course (per the aforementioned article), a basic finance course, and maybe an accounting course.

Maybe there are others that should be a requirement as well?


Major joint replacements cost Medicare more than $6B in 2011

Yesterday there was quite a bit of buzz about the release of Medicare’s inpatient payments for the top 100 diagnosis related groups.  The Washington Post published some highlights on the data including a neat widget to visualize the data.  We decided to take our own shot at it.  This was a fun dataset for us since we were able to leverage a ton of work that we’ve already done.  We had already standardized entities for hospital, organization, DRG, and city from other CMS datasets.  I downloaded the data at 3 PM and had it up and running on karmadata by 5.  We added a couple of calculated measures for total amount paid by Medicare and discrepancy between amount charged and amount received, and started making datacards.

Here’s what folks are saying:


Founded by Sean Power, previous founder of Infinata (BioPharm Insight®), karmadata curates and provides access to a linked version of the world’s open data sources in Healthcare, Legal, Energy, and other verticals.

BOSTON, May 7, 2012 – karmadata officially introduced its freemium website (www.karmadata.com) and API (www.karmadata.com/API) to the global data community at the Data 2.0 Summit, held April 30th in San Francisco. karmadata’s website enables users to find, visualize and share data of interest to them and their social networks. The karmadata API provides standardized linked data from the world’s data sources, allowing developers to design and build their own applications.

“The Data 2.0 Summit (www.data2x.com) was the perfect arena for us to announce our launch amongst so many creative and like minded leaders in the data industry. Our website will reinvent how professionals access and analyze data, providing access to 10s of millions of users that are blocked by proprietary corporate-only license fee models. Additionally, our API will provide simple, affordable access to standardized, linked data for app developers and system integrators to create things we couldn’t possibly dream of,” said Sean Power founder and CEO of karmadata.

karmadata was chosen as one of the top 5 data startups of 2013 to present during the Data 2.0 Summit. “karmadata’s vision and technology platform fit our 2013 conference theme of ‘Democratizing Data’ perfectly. We welcome their entrance and look forward to their disruptive activities in the business information space,” said Geoff Domoracki, co-founder of Data 2.0.

karmadata poised to disrupt the Professional Business and Information Services Industry

The current Professional Business and Information Services industry is a $100 billion + market, dominated by a handful of Big Information Vendors which utilize a corporate-only, up-front licensing model. This archaic standard effectively locks out tens of millions of would-be users and application developers who generally cannot afford the upfront costs of access. karmadata is utilizing innovative technology and cloud based scale, enabling a first-in-kind freemium pricing model for industry data.

How karmadata works

On a daily basis, karmadata processes high value open data sources, such as: PubMed, ClinicalTrials.gov, the FDA Adverse Events Reporting System, the USPTO databases, and many others. These sources are primarily semi-structured text or XML that are not linked to each other, and provide no standards for querying, analyzing or visualizing. We have processed over 100 million records to date, and have identified over 6.1 million Entities that are healthcare providers, populated places, clinical investigators, diseases, organizations, drugs and more.

karmadata visitors can create “Datacards”©, which are meant to be mini-blogs, telling a data-driven and visualized story that is personal for the author. These Datacards can be easily shared on social media, third-party websites or embedded in blogs or articles on the web. Additionally, each of our 6.1 million Entities has its own Poster, with visualizations and an index to all the world’s data where that person, place, organization, product or thing can be found.

About karmadata

karmadata is on a mission to standardize and link the world’s data and to provide easy affordable access to it, to anyone, anywhere in the world. karmadata is currently a small and enterprising team of dedicated and experienced professionals with a common goal of redefining the industry standards of how data will be resourced, collated and shared among industry professionals and setting the gold standard for future data providers.

Currently seeking partnerships and investors

karmadata is actively recruiting investment, data provider and technology partnerships. For more information please contact Sean Power (media@karmadata.com)

EMA drug approvals

We recently added the European public assessment reports (EPAR) data set.  Here is a rank of non-generic EMA product approvals since 2009 by company.

@Data2x Summit Live Blog

yesi79 —  April 30, 2013 — Leave a comment


9:15am: Opening Keynote by James Strittholt

James Strittholt @data2xDataBasin.org

James Strittholt delivers the keynote at Data2.0 Summit on Climate Change through GEO data. James provided an amazing live demo of DataBasin.org in which he visualized the effects of climate change via interactive and configurable maps in realtime with high quality data.

9:50am: Heard a great quote

“90% of the world’s data has been added in the last two years”

10am: PANEL: From Climate Data To Technology Solutions


Great discussion by the panel and was very impressed by Daniel Goldfarb, Partner, Director of Design Research, Greenstart who provided great insights in the current data inustry. Below are a few quotes by Daniel:

“The amount of ‘dashboard’ startups we see is staggering, but simply having a lot of data is not a business model. There’s a need for actionable end points for data driven decision making.”

“Gamification is the worst word in our industry. It doesn’t do anything in most cases.”

“Did you know that some of the small utility companies contract outside firms to retrieve email address of their own customers?”

A great question posed by Daniel Goldfarb: “Which car type do you think will be more prevalent in the next five years, EV or Self Driving cars?”

10:50am: PANEL: Data Science and Algorithms-as-a-Service
With a QA format, I’ve found it easier to jot down the best answers heard during the panel. Data is heavy but algorithms are light. Best strategy to address this difference is to place the algorithm where the data lives. A new strategy is to “burn” the model (IF THEN statements) into the chips themselves. Do you think data as service replaces data scientists? Absolutely not. How to use data successfully and what questions to ask become very important. There are many companies and organizations out there who don’t know they have data problems.

Algorithmia: Interesting startup that provides a marketplace for connecting algorithm developers with companies needing solutions.

12pm: Crowdsourcing the Oct Dataweek conference
During lunch the lead organizers of Data2.0 asked all of us to suggest topics we’d like to be covered at the next Data2.0 conference. Of the ideas suggested, then voted on by everyone, Data Predictability was at the top of the list.

12:30pm: Disqus demo of Gravity

Disqus Gravity

12:40pm: Fibit demo’d their latest product, app and API
Fitbit API can be reviewed here

3:20pm: PANEL: Democratizing Data: A business, technology, and society problem
How do we democratize the power of data? On the question of what are the inhibiters to democratizing data, Bruno Aziza from SiSense provided fantastic insights. Bruno outlined a few top inhibiters:

  1. Price: It’s currently too high a price to gain access to the data
  2. There’s an imbalance with the cost of storage versus crunching the data. It currently costs $1M to crunch 1TB of data versus the very cheap costs to store it.
  3. Although complex, we shouldn’t take an elitist closed approach to analyzing data. We should enable the consumer to analyze on their own without the need for experts.

Diego Oppenheimer from Microsoft touched upon the need for education to the consumer. With the increase of easy to use tools being created, how do we reduce the risk of incorrect conclusions made by the user.

On the question of how can we make users more data savvy, Diego pointed out that the issue starts with the fact that data is not clean and thus un-appealing to users to even get started. Diego mentioned that Microsoft has taken a visual and explorer approach with their Data Explorer product offering.

4:10pm Top 5 Startup Pitch Event
Out of 20 startup applicants across the country, karmadata was chosen along with 4 other startups to present during the Startup Pitch event. The other startups include Algorithms.io, MarkedUp, Vertascale and Virtue. You can read about them here.

Sean Power presenting at #data2summit #startup pitch event.

4:50pm PANEL: Big Friendly Data: Making Big Data Accessible to Non-wizards
How much of their own data is the average organization using? Only 15%. Organizations today can improve their use of data by simply taking a closer look at their own data.

What is the holy grail? It’s being able to take any business problem, use the data you already have and work with your current resources/team to reduce the amount of time to market (within 30days).

5:20pm: Top Startup Announced
Algorithmia.io was selected as the top startup.

Orphan Drug Designations

Orphan drugs have been a hot topic of late.  We created this card which shows a steady increase in the number of companies receiving orphan drug designations from the FDA.


This datacard caught our eye since we’ve seen recent news reports on the increased requests by foreign governments for user data to Google and Microsoft as reported by Forbes. Events such as Monday’s Boston bombings likely cause a spike in such activity (and for good reason).

In order to force ourselves into good habits for pushing out new content, we’ve committed to publishing a blog post every Wednesday.  Last night I began writing this week’s post about Monday’s tragic events at the Boston Marathon.  I got pretty much nowhere before calling it quits.  All I had done was come up with disclaimers to preface the post with:

“Fortunately, none of us at the company were directly affected.”

“The internet is inundated with content on this subject, and there are thousands of people more profoundly impacted by the events who can articulate their sentiments much more eloquently than I can.”

“None of my thoughts are necessarily original, and have all been intimated in some media outlet or another.”

“This blog isn’t designed to address heavy matters such as this one.”

Ultimately, I went to bed deciding that I would just write about something normal.

But coming into the office this morning, writing about something “normal” didn’t feel right either.  We are a Boston company, these events have affected us, and since I am writing today, then today I will write about Monday’s events.

The Boston Marathon is almost a sacred event to Bostonians.  I’ve heard many people refer to it in recent days as not so much an athletic event as it is a festival celebrating the city’s proud history and heritage.  In a city that identifies itself with its sports teams, the Red Sox play a special 11 AM game every year to coincide with the race.  The route goes by many of the city’s great colleges which adds a particularly festive vibe (that might be putting it lightly).  It takes place on Patriots’ Day, commemorating the Battles of Lexington and Concord which kickstarted the founding of this nation.  It is the world’s oldest annual marathon.  Boston is often overshadowed as the little, kid brother of New York City, and while we might think the Boston Marathon is a bigger deal than it actually is, this is our event, our time to show off how great our city truly is.

Growing up outside of Boston and then attending a college at the top of Heartbreak Hill, I always dreamed of one day running the marathon.  Attending the race, you cannot help but be inspired by runners fighting through injuries and fatigue, or running in memory of a lost loved one, or for one of the many charities that raises money through the event, or by a father who pushes his son with cerebral palsey every year.  You wonder what that sense of accomplishment must feel like.

In 2011 I finally realized my lifelong dream.  I ran by friends and family, planted kisses on the cheeks of the Wellesley College girls at mile 12, climbed the Newton Hills passing the Hoyt’s along the way at mile 19, climbed Heartbreak Hill at mile 21, got an enormous adrenaline rush running by my alma mater shortly thereafter, ran by the Red Sox fans in Kenmore Square at mile 25, and then took the famous right on Hereford.

Chills came over me as I took the final turn onto Boylston.  The spectacle, the crowd noise, the finish line finally in sight.  I scanned the crowd knowing my dad was somewhere among those thousands.  In a scene that I can still playback like a movie, I heard him yell out to me and saw him smiling ear to ear.  The fatigue in your legs disappears, and you move forward uncontrollably.  The feeling of crossing the finish line is unlike anything I have ever experienced.  It’s not just the culmination of 26.2 miles, but the culmination of months of arduous training.

This is all to say that thousands of people were robbed of this moment on Monday.  Much worse, lives and limbs were taken from innocent spectators and participants.  What is supposed to be a joyous stretch of pavement became the scene of a horrific and disgusting act.

After running the last two marathons, I decided to take in this year’s as a spectator for the first time as an alumnus.  We stationed ourselves at a friend’s apartment around mile 23 of the route.  Roughly ten minutes after my friend and marathon teammate ran by us, I received a disturbing text from a friend located on Boylston.  I did some quick math and figured that my friends were likely short of the finish line.  Fortunately, they were about a third of a mile from the explosions and were unharmed.  We frantically ran down the checklist of friends and family in the area, and were able to confirm everyone’s safety relatively quickly.

It’s very easy to play the what if game with something like this.  What if my friends had been a little faster (actually more on target with what they hoped for, if not for some cramps)?  What if we had already made it to the finish area?  What if my sister, who was on the subway heading in town, had left a little earlier?  What if I had run this year?  What if my dad was in the same spot he was 2 years ago?  Well, for the 3 dead and 150 injured and their families, there is no what if game.  Our hearts and prayers go out to all of them.

But much like every other Marathon Monday, this day showed off how great our city truly is.

First responders sprinting towards the explosions to help the wounded.  The best hospitals in the world mobilizing and treating victims.  Marathoners crossing the finish line only to continue their run to the hospital to donate blood.  Residents offering up places to stay for those displaced by the crime scene.

Boston is stronger today than it ever has been.  Marathon Monday will forever be different, but it will go on, and it will still showcase Boston’s finest.  I look forward to running next year.  My friends who had their finishing moment stolen are looking forward to it as well.